Pandemic onset stalled reduction of benzodiazepine use among older Americans, says study

A decade-long study from Columbia University reveals that the steady decline in benzodiazepine prescriptions for older Americans stalled following the onset of the COVID-19 pandemic. Researchers noted an increase in usage among adults aged 75 and older, raising concerns due to the medication's known risks of cognitive impairment and falls.